MODERN CHI MED obtains Stock Exchange waiver, extends major-transaction circular deadline to 30 June 2026

Bulletin Express05-07

Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) has secured a further waiver from the Hong Kong Stock Exchange regarding Rule 14.41(a) of the Listing Rules, allowing additional time to dispatch its major-transaction circular.

The circular, covering details of the share-purchase agreement, audited financial statements of the target group for the three years ended 31 December 2025, and pro forma financial information of the enlarged group, was originally due on or before 30 April 2026. The revised deadline is now on or before 30 June 2026.

The Stock Exchange granted the waiver on 6 May 2026. The regulator reserves the right to withdraw or amend the waiver should circumstances change.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment